Job placement company APM Human Services International has won new government contracts that could increase its foot print in Australia by 50%
Following FY21 results for Sigma Healthcare brokers see an uncertain outlook for near-term earnings
ResMed has struggled to realise the benefit promised by a major competitor recall and heightened demand amid a global shortage of semiconductor chips necessary for device production
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Following first half results for Premier Investments, brokers generally set higher target prices and noted leverage towards both stay-at-home and re-opening thematics
With a potential end in sight for Fisher & Paykel Healthcare’s covid benefits the company looks to prove its ventilation devices have a place outside of intensive care units and rebuild utilisation rates for a sustainable outlook
Following first half results for New Hope, brokers focused not only on the surprise special dividend but also on prospects for future distributions
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
The current share price might be underestimating potential upside for Seek
Two of Rio Tinto’s major growth projects are currently beholden to geopolitical influences, positive and negative, and it’s got nothing to do with the war